Lacmellea oblongata

Lacmellea oblongata fruit contains exceptionally high concentrations of citric acid (3589.7 mg/100 g DW) alongside the flavanone naringenin and chlorogenic acid (213.8 mg/100 g DW), which collectively drive its antioxidant and antimicrobial activity. In vitro screening has shown the fruit extract inhibits oral pathogens Streptococcus mutans (MIC 10.4 mg/mL), Candida albicans, and Candida tropicalis (MIC 20.8 mg/mL each), representing the sole quantified efficacy data available to date.

Origin & History

Lacmellea oblongata is a wild Amazonian fruit tree belonging to the family Apocynaceae, native to the tropical rainforest regions of South America, particularly the Amazon basin. The species thrives in the humid, biodiverse lowland forest ecosystems characteristic of the western Amazon, where it grows as a canopy or sub-canopy tree under conditions of high rainfall and rich alluvial soils. Until very recently it remained botanically understudied, with formal phytochemical characterization of its fruit only reported for the first time as of approximately 2023–2024.

Historical & Cultural Context

Lacmellea oblongata belongs to the genus Lacmellea, which comprises roughly 15 species distributed across Central and South American tropical forests, several of which are valued by indigenous Amazonian communities as sources of edible fruit and latex. The related species Lacmellea standleyi, known regionally as 'lechemiel' in parts of Central America, has documented traditional use as a food source and has been subjected to limited extraction methodology studies, providing contextual analogy for the genus's cultural relevance. Formal ethnobotanical records specifically documenting traditional medicinal or culinary use of Lacmellea oblongata by Amazonian peoples have not yet been published in the accessible scientific literature, representing a significant documentation gap given that local communities in biodiverse Amazonian regions frequently possess extensive empirical knowledge of native fruit species. The genus name Lacmellea references the milky latex characteristic of Apocynaceae family members, which in related species has historically drawn attention as a potential source of bioactive secondary metabolites.

Health Benefits

- **Antioxidant Activity**: The fruit contains naringenin and chlorogenic acid, polyphenols that scavenge free radicals as measured by validated ABTS and DPPH assays, potentially reducing oxidative stress at the cellular level.
- **Antimicrobial Properties**: Aqueous or solvent extracts inhibit the oral cariogenic bacterium Streptococcus mutans at an MIC of 10.4 mg/mL and the opportunistic yeasts Candida albicans and Candida tropicalis at 20.8 mg/mL in vitro, suggesting relevance to oral and mucosal health.
- **High Organic Acid Content**: With citric acid levels of 3589.7 ± 11.4 mg/100 g DW—substantially exceeding other evaluated Amazonian fruits—Lacmellea oblongata may support metabolic pathways involving the tricarboxylic acid cycle and mineral bioavailability enhancement through chelation.
- **Phenolic Compound Richness**: The presence of chlorogenic acid, a hydroxycinnamic acid derivative, is associated with inhibition of glucose-6-phosphatase and modulation of postprandial glucose absorption, though these effects have not been tested directly in this species.
- **Flavanone Bioactives**: Naringenin, a principal flavanone identified in the fruit, is documented in related research to modulate NF-κB signaling and exhibit anti-inflammatory effects, providing a mechanistic basis for broader investigation of this fruit.
- **Carotenoid Presence**: The fruit reportedly contains carotenoids, compounds associated with pro-vitamin A activity and antioxidant quenching of singlet oxygen, though specific concentrations have not yet been published for this species.

How It Works

Chlorogenic acid exerts antioxidant effects primarily through direct radical scavenging via its catechol moiety and secondarily by chelating transition metal ions that catalyze Fenton-type oxidative reactions; it also inhibits lipid peroxidation by interrupting chain propagation reactions. Naringenin modulates cellular redox status by activating the Nrf2/Keap1 pathway, upregulating endogenous antioxidant enzymes including superoxide dismutase and glutathione peroxidase, while its antimicrobial activity is attributed to disruption of bacterial cell membrane integrity and inhibition of biofilm formation. Citric acid, present at extraordinarily high concentrations, functions both as a chelating agent that sequestrates divalent metal cations essential for microbial enzymatic activity and as a pH-lowering acidulant that creates an inhospitable environment for pathogen proliferation. The combined action of these compounds in the whole-fruit matrix likely produces additive or synergistic antimicrobial effects, though no mechanistic co-assay data currently exist for Lacmellea oblongata specifically.

Scientific Research

The evidence base for Lacmellea oblongata is at an early preclinical stage; as explicitly noted by researchers, no studies had characterized its bioactive compounds prior to the initial phytochemical report published approximately 2023–2024, making this one of the most recently characterized Amazonian fruits in the literature. Available data derive entirely from in vitro phytochemical characterization studies and laboratory antimicrobial screening using minimum inhibitory concentration (MIC) methodology against three microbial species, with no animal studies, pharmacokinetic analyses, or human trials reported. Antioxidant capacity was quantified using ABTS and DPPH radical scavenging assays, which are standardized screening tools but are not predictive of in vivo antioxidant efficacy due to absorption, distribution, and metabolic transformation variables. No peer-reviewed randomized controlled trials, cohort studies, or systematic reviews have been published for this species, and the evidence remains insufficient to support therapeutic or nutraceutical claims beyond preliminary phytochemical interest.

Clinical Summary

No clinical trials have been conducted in human subjects with Lacmellea oblongata extract, fruit, or any derived preparation as of 2025. The entirety of available efficacy data originates from in vitro experiments characterizing phytochemical composition and performing antimicrobial MIC assays, which represent the foundational step of drug or nutraceutical discovery pipelines rather than clinical evidence. Effect sizes reported (MIC values of 10.4–20.8 mg/mL) reflect laboratory concentrations that have not been validated for achievability or safety at systemic levels in vivo. Confidence in clinical benefit is therefore very low, and extrapolation from current data to human health outcomes is speculative; the ingredient warrants further investigation through preclinical toxicology, pharmacokinetics, and eventually human pilot studies.

Nutritional Profile

Lacmellea oblongata fruit is characterized by an exceptionally high organic acid content dominated by citric acid at 3589.7 ± 11.4 mg/100 g dry weight, a concentration reported to exceed that of other Amazonian fruits evaluated in comparative studies. Phenolic compounds include chlorogenic acid at 213.8 ± 16.9 mg/100 g DW and naringenin at a concentration not yet precisely quantified in published literature. Carotenoids have been qualitatively identified but not quantified, and ascorbic acid (vitamin C) was not detected (below detection limit) in the analyzed samples, distinguishing it from related Amazonian fruits such as Grias neuberthii (25.4 mg/100 g DW) and Miconia crenata (12.5 mg/100 g DW). Macronutrient composition, mineral content, dietary fiber, total sugar profile, and fat-soluble vitamin content have not been published, and bioavailability of its phenolic compounds under gastrointestinal conditions has not been studied.

Preparation & Dosage

- **Fresh Fruit (Traditional/Whole Food)**: No standardized dose established; consumed as a whole fruit in its native Amazonian range where local knowledge exists, though formal ethnobotanical documentation is lacking.
- **Aqueous Extract (Laboratory Reference)**: Research antimicrobial assessments used water-based extractions yielding concentrations sufficient to achieve MIC values of 10.4–20.8 mg/mL against test pathogens; equivalent human-relevant dosing has not been calculated.
- **Standardized Supplement Forms**: No commercial supplement, capsule, powder, or extract formulation has been documented or approved for Lacmellea oblongata as of 2025.
- **Standardization Markers**: Chlorogenic acid (target: 213.8 mg/100 g DW equivalent) and naringenin could serve as future standardization markers, but no industry standard currently exists.
- **Timing and Administration Notes**: Without human pharmacokinetic data, no evidence-based guidance on dosing frequency, timing relative to meals, or route of administration can be provided.

Synergy & Pairings

Naringenin, one of Lacmellea oblongata's identified flavanones, is documented in the broader flavonoid literature to exhibit enhanced bioavailability and anti-inflammatory synergy when combined with hesperidin or quercetin, as these compounds share overlapping Nrf2 pathway activation and mutual inhibition of COMT-mediated metabolic degradation. Chlorogenic acid has demonstrated additive antimicrobial effects against Streptococcus species when combined with other phenolic acids such as caffeic acid, suggesting potential synergy if Lacmellea oblongata extracts are combined with other polyphenol-rich Amazonian fruits. The high citric acid content may theoretically enhance absorption of co-administered mineral supplements (iron, zinc, calcium) through chelation-mediated solubilization in the gastrointestinal lumen, a synergy well-established for citric acid from other sources.

Safety & Interactions

No toxicological studies, safety pharmacology evaluations, or adverse event data have been published for Lacmellea oblongata in any form, representing a critical gap that precludes confident safety characterization. The very high citric acid content (3589.7 mg/100 g DW) warrants consideration in individuals with gastroesophageal reflux disease, erosive esophagitis, or dentinal sensitivity, as chronic high citric acid exposure is associated with dental enamel erosion and mucosal irritation. No drug interaction data exist; however, chlorogenic acid from other plant sources has been noted in preclinical contexts to potentially influence cytochrome P450 enzyme activity and glucose transporter function, suggesting theoretical interactions with antidiabetic or anticoagulant medications that should be monitored if human use is contemplated. Use during pregnancy or lactation cannot be evaluated due to complete absence of safety data, and the ingredient should be treated as having an unestablished safety profile until formal toxicological assessment is completed.